BETA-RECEPTOR BLOCKERS

 Toxicology

  • Beta-blockers act as competitive inhibitors of catecholamines at both central and peripheral receptors. Blockade of beta-receptors results in decreased production of intracellular cAMP  which in turn suppresses multiple metabolic and cardiovascular effects of circulating catecholamines. Myocardial conduction delays with decreased contractility mostly describe acute beta-blocker ingestion.
  • Beta1-receptor blockade decreases heart rate, blood pressure, myocardial contractility, and myocardial oxygen consumption. Beta 2-receptor blockade inhibits relaxation of smooth muscle in blood vessels, bronchi, the gastrointestinal system, and the genitourinary tract.
  • Beta-adrenergic receptor blockers inhibits both glycogenolysis and gluconeogenesis, thereby . . .

    Please Subscribe to continue reading